Edition:
United States

Insider Trading: Anthera Pharmaceuticals Inc (ANTH.O)

ANTH.O on Consolidated Issue listed on NASDAQ Global Market

1.35USD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$1.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
281,658
52-wk High
$27.36
52-wk Low
$1.20

All Insider Trades
Trading Date Name Title Type Shares Traded Price
6 Sep 2017

Truex (Paul F)

Director Buy 5,000 $1.34
6 Sep 2017

Thompson (John Craig)

Chief Executive Officer Buy 10,400 $1.43
10 Jan 2017

Olson (Charles V)

Chief Technology Officer Buy 7,767 $0.55
10 Jan 2017

Thompson (John Craig)

Chief Executive Officer Buy 7,190 $0.55
19 Sep 2016

Truex (Paul F)

Chief Executive Officer Gift 5,008 $0.00
19 Sep 2016

Truex (Paul F)

Chief Executive Officer Buy 5,008 $2.08
19 Sep 2016

Truex (Paul F)

Chief Executive Officer Gift 5,008 $0.00
29 Jun 2016

Olson (Charles V)

Chief Technology Officer Buy 1,789 $2.63
22 Dec 2015

Mueller Brian R

Director Buy 10,000 $2.89
10 Nov 2015

Hislop (Colin)

Officer Sell 5,000 $5.38
11 Oct 2015

Odink (Debra)

Chief Technology Officer Sell 1,205 $6.15

Institutional Holders

% Shares Owned: 29.16%
# of Holders: 60
Total Shares Held: 3,179,812
3 Mo. Net Change: -267,706
# New Positions: 6
# Closed Positions: 40
# Increased Positions: 22
# Reduced Positions: 62
# Net Buyers: -40

Officers & Directors

Name Age Since Current Position

Paul Truex

2016 Executive Chairman of the Board

Craig Thompson

50 2016 President, Chief Executive Officer, Chief Operating Officer, Director

May Liu

39 2013 Senior Vice President - Finance and Administration, Principal Accounting Officer

William Shanahan

68 2016 Chief Medical Officer

Brent Furse

47 2016 Director

Christopher Henney

76 2016 Independent Director

Brian Mueller

43 2014 Independent Director

Philip Sager

59 2014 Independent Director

David Thompson

67 2005 Independent Director